Search and Filter
Results per Page:
Probing the predictive power of precision diagnostics
From the Etzioni Group, Public Health Sciences Division and the Cancer Consortium
Dr. Heather Parsons to lead Fred Hutch’s breast cancer initiatives
Medical oncologist awarded endowed chair to study novel markers for cancer in blood serum
Glitch to switch: Turning spliceosome mutations into immune targets
From the Bleakley Lab, Translational Science and Therapeutics Division
TakePART-NW, an ambitious new precision oncology research program, launches at Fred Hutch
Patients who opt in may help solve the mysteries of cancer and other diseases
New funding drives six breast cancer studies
Scientists from Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium receive $1.7M in grants from Breast Cancer Research Foundation
Fred Hutch expands its research capacity in South Lake Union
Three new buildings will boost recruitment and strengthen science
Cancer centers launch Cancer AI Alliance to unlock discoveries, transform care using cancer data and applied AI
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding
Mapping tumor cell heterogeneity in castrate-resistant prostate cancer
From the Haffner Lab, Human Biology and Clinical Research Divisions
A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
When it comes to low-affinity HER2 CAR T cells, less is more
From the Riddell lab, Translational Science and Therapeutics Division and Cancer Immunology Program
A tale of two T cells in Merkel Cell Carcinoma
From the Newell Lab, Vaccines and Infectious Disease Division
New techniques, collaborations push patient-focused precision oncology forward
$5.4M NCI award supports Dr. Chris Kemp’s multi-disciplinary discovery platform for cancer-therapy targets
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
Behnke family commits $15M to support Fred Hutch campaign
Patient lodging in South Lake Union will be renamed in family’s honor
2023: The Year in Photos
A look back at the important moments for Fred Hutch through photos
Multiple myeloma research to be presented at American Society of Hematology annual meeting
Dr. Rahul Banerjee to share insights on reducing financial toxicity, time toxicity and side effects of treatment
Abnormal bone marrow findings post CAR-T cell therapy help uncover responses to treatment
From the Yeung and Naresh labs, Translational Sciences and Therapeutics Division